Directorate Change

20 December 2021

Venture Life Group plc

("Venture Life" or the "Company")

Directorate Change

Venture Life (AIM: VLG), a leader in developing, manufacturing and commercialising products for the self-care market, is pleased to announce that Mr Daniel Wells, appointed as Chief Financial Officer at the time of the trading update announcement on 1 December 2021, has joined the Board with immediate effect.

Further information on Daniel Wells

Daniel James Wells (aged 34) has in the last five years been a director of The Green (Stoke Park) Management Company Limited and is currently a director of Susandan Limited.

There is no further information on Daniel Wells required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies.

For further information please contact:

About Venture Life (www.venture-life.com)

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in both the UK and Italy, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for lowering cholesterol and maintaining brain function, medical devices for women's intimate healthcare and proctology and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK these are supplied direct by the company, outside of the UK they are supplied by the Group's international distribution partners. 

Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.